https://www.indianpharmapost.com/dupixent-is-now-approved-in-india-for-the-treatment-of-adults-with-moderate-to-severe-atopic-dermatitis-143872023-07-14T00:00:00+05:30always0.9https://www.indianpharmapost.com/lupin-receives-approval-from-usfda-for-chlorpromazine-hydrochloride-tablets-usp-143882023-07-14T00:00:00+05:30always0.9https://www.indianpharmapost.com/granules-india-announces-approval-for-acetaminophen-and-ibuprofen-tablets-143892023-07-14T00:00:00+05:30always0.9